Cargando…
Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers
BACKGROUND: Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The l...
Autores principales: | Hoonhorst, Susan J. M., ten Hacken, Nick H. T., Vonk, Judith M., Timens, Wim, Hiemstra, Pieter S., Lapperre, Thérèse S., Sterk, Peter J., Postma, Dirkje S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914834/ https://www.ncbi.nlm.nih.gov/pubmed/24505290 http://dx.doi.org/10.1371/journal.pone.0087443 |
Ejemplares similares
-
Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial
por: Snoeck-Stroband, Jiska B., et al.
Publicado: (2015) -
Inhaled Steroids Modulate Extracellular Matrix Composition in Bronchial Biopsies of COPD Patients: A Randomized, Controlled Trial
por: Kunz, Lisette I. Z., et al.
Publicado: (2013) -
Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers
por: Willemse, Brigitte WM, et al.
Publicado: (2005) -
Acute effects of cigarette smoking on inflammation in healthy intermittent smokers
por: van der Vaart, Hester, et al.
Publicado: (2005) -
Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease
por: Budulac, Simona E., et al.
Publicado: (2012)